Literature DB >> 34325682

So many ways to naturally kill a cancer cell.

Timothy J Mitchison1.   

Abstract

Natural killer (NK) cells participate in cancer immunosurveillance and cancer immunotherapy. Live cell imaging of cancer cells targeted by NK cells, published today in BMC Biology by Zhu et al., reveals a remarkable diversity of programmed cell death pathways induced in individual cells. Pathway choice depends on the state of the target cell actin cytoskeleton and a novel death pathway, granzyme-induced necroptosis, could be of broad importance in cancer immunotherapy.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID： 34325682     DOI： 10.1186/s12915-021-01092-3

Source DB:  PubMed          Journal:  BMC Biol        ISSN： 1741-7007            Impact factor:   7.431


  9 in total

Review 1.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 2.  Mechanisms of natural killer cell-mediated cellular cytotoxicity.

Authors:  Isabel Prager; Carsten Watzl
Journal:  J Leukoc Biol       Date:  2019-05-20       Impact factor: 4.962

Review 3.  Activation, coactivation, and costimulation of resting human natural killer cells.

Authors:  Yenan T Bryceson; Michael E March; Hans-Gustaf Ljunggren; Eric O Long
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

Review 4.  Natural killer cells and other innate lymphoid cells in cancer.

Authors:  Laura Chiossone; Pierre-Yves Dumas; Margaux Vienne; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2018-11       Impact factor: 53.106

Review 5.  Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.

Authors:  Kari A Shaver; Tayler J Croom-Perez; Alicja J Copik
Journal:  Front Immunol       Date:  2021-04-28       Impact factor: 7.561

Review 6.  The role of necroptosis in cancer biology and therapy.

Authors:  Yitao Gong; Zhiyao Fan; Guopei Luo; Chao Yang; Qiuyi Huang; Kun Fan; He Cheng; Kaizhou Jin; Quanxing Ni; Xianjun Yu; Chen Liu
Journal:  Mol Cancer       Date:  2019-05-23       Impact factor: 27.401

Review 7.  When and how NK cell-induced programmed cell death benefits immunological protection against intracellular pathogen infection.

Authors:  José E Belizário; Jennifer M Neyra; Maria Fernanda Setúbal Destro Rodrigues
Journal:  Innate Immun       Date:  2018-09-20       Impact factor: 2.680

8.  Myosin phosphatase is inactivated by caspase-3 cleavage and phosphorylation of myosin phosphatase targeting subunit 1 during apoptosis.

Authors:  Takahiro Iwasaki; Takeshi Katayama; Kazuhiro Kohama; Yaeta Endo; Tatsuya Sawasaki
Journal:  Mol Biol Cell       Date:  2013-01-23       Impact factor: 4.138

9.  Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.

Authors:  Lauren Mifflin; Dimitry Ofengeim; Junying Yuan
Journal:  Nat Rev Drug Discov       Date:  2020-07-15       Impact factor: 112.288
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.